Literature DB >> 6753230

Bleeding time in rats: a comparison of different experimental conditions.

E Dejana, S Villa, G de Gaetano.   

Abstract

The tail bleeding time (BT) in rats definitely varies according to the method applied. Of the various variables that may influence BT, we have evaluated the position (horizontal or vertical) of the tail, the environment (air or saline), the temperature (4 degrees, 23 degrees or 37 degrees C) and the type of anaesthesia. Transection of the tail tip cannot be used to screen drugs active on platelet function since it is sensitive to coagulation defects. Template BT in contrast is not modified by heparin and is sensitive to defects of platelet number and function ("storage pool disease", dipyridamole-like drugs, exogenous prostacyclin). In contrast the test fails to detect aspirin-induced platelet dysfunction. The evidence reported indicates that thromboxane A2-prostacyclin balance is not a factor regulating BT. Aspirin treatment however may be a precipitating factor when associated with other abnormalities of platelet function. Template BT is a valid screening test for platelet disorders and for antiplatelet drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753230

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  22 in total

Review 1.  Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

Authors:  N Taniguchi; S Ihara; T Saito; E Miyoshi; Y Ikeda; K Honke
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  An αIIbβ3- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis.

Authors:  Jian Jing; Yanna Sun
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

3.  Bleeding times and the antithrombotic effects of high-dose aspirin, hirudin and heparins in the rat.

Authors:  S M Lavelle; M MacIomhair
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

4.  NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.

Authors:  Heng-Lan Kuo; Jin-Cherng Lien; Ching-Hu Chung; Chien-Hsin Chang; Shyh-Chyi Lo; I-Chun Tsai; Hui-Chin Peng; Sheng-Chu Kuo; Tur-Fu Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

5.  NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.

Authors:  Heng-Lan Kuo; Jin-Cherng Lien; Chien-Hsin Chang; Ching-Hu Chung; Sheng-Chu Kuo; Chun-Chieh Hsu; Hui-Chin Peng; Tur-Fu Huang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

6.  Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist.

Authors:  C H Yeh; M C Chang; H C Peng; T F Huang
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.

Authors:  M Kyogashima; T Sakai; J Onaya; A Hara
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

8.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

9.  Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk.

Authors:  Bingxing Shi; Aiping Yu; Yuying Liu; Jingchuan Li; Jide Jin; Chunna Dong; Chutse Wu
Journal:  J Thromb Thrombolysis       Date:  2007-05-09       Impact factor: 2.300

10.  Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine.

Authors:  F De Clerck; Y Somers; L Van Gorp
Journal:  Agents Actions       Date:  1984-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.